Overview

Kronos Early Estrogen Prevention Study (KEEPS)

Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition.
Phase:
Phase 4
Details
Lead Sponsor:
Kronos Longevity Research Institute
Collaborators:
Albert Einstein College of Medicine
Albert Einstein College of Medicine of Yeshiva University
Brigham and Women's Hospital
Columbia University
Mayo Clinic
University of California, San Francisco
University of Utah
University of Washington
Yale University
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Estrogens, Conjugated (USP)
Polyestradiol phosphate
Progesterone